These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 17036904)

  • 1. [Management of chronic pain using extended release tilidine : Quality of life and implication of comedication on tilidine metabolism].
    Wolfert C; Merbach M; Stammler G; Emrich O; Meid AD; Burhenne J; Blank A; Mikus G
    Schmerz; 2017 Oct; 31(5):516-523. PubMed ID: 28597312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tilidine/naloxon retard in long-term administration in chronic pain and multimorbidity. Multicenter study of long-term tolerance and effectiveness in 2 years observation].
    Flöter T; Brunnmüller U
    Fortschr Med Orig; 2002; 120(1):29-35. PubMed ID: 14518355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic pain due to degenerative and inflammatory musculoskeletal diseases in the elderly. Observational study investigating dosage, course of treatment, effectiveness and tolerability of tilidine/naloxone].
    von Renteln-Kruse W; Sarnow E; Schenkel I
    MMW Fortschr Med; 2005 Jun; 147(25):41. PubMed ID: 16038340
    [No Abstract]   [Full Text] [Related]  

  • 4. [Long-term treatment of chronic pain with tilidine-naloxone. An analysis of 50 patients with chronic pain conditions of non-malignant origin].
    Wörz R; Wörz E
    Fortschr Med; 1995 Sep; 113(27):388-92. PubMed ID: 7498863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The transdermal 7-day buprenorphine patch--an effective and safe treatment option, if tramadol or tilidate/naloxone is insufficient. Results of a non-interventional study].
    Schutter U; Ritzdorf I; Heckes B
    MMW Fortschr Med; 2010 Jul; 152 Suppl 2():62-9. PubMed ID: 21591321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tilidine-Naloxone sustained-release tablets for chronic pain associated with musculoskeletal disease].
    Junker U; Sarnow E; Tilke C
    MMW Fortschr Med; 2006 Sep; 148(37):45. PubMed ID: 17036904
    [No Abstract]   [Full Text] [Related]  

  • 7. Topical review on the abuse and misuse potential of tramadol and tilidine in Germany.
    Radbruch L; Glaeske G; Grond S; Münchberg F; Scherbaum N; Storz E; Tholen K; Zagermann-Muncke P; Zieglgänsberger W; Hoffmann-Menzel H; Greve H; Cremer-Schaeffer P
    Subst Abus; 2013; 34(3):313-20. PubMed ID: 23844964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Low-dose strong opioid (LDSO)--treatment of pain in osteoarthritis].
    Bolten WW; Böhme K; Grifka J; Schutter U; Schwarz H; Sittl R; Sturm D; Wahle K
    MMW Fortschr Med; 2008 Dec; 150(51-52):41. PubMed ID: 19156956
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic pain of osteoarthritis: considerations for selecting an extended-release opioid analgesic.
    Gibofsky A; Barkin RL
    Am J Ther; 2008; 15(3):241-55. PubMed ID: 18496262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KADIAN (morphine sulfate extended-release) capsules for treatment of chronic, moderate-to-severe, nonmalignant pain.
    Ross EL; Hahn K
    Int J Clin Pract; 2008 Mar; 62(3):471-9. PubMed ID: 18261077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.